Season 1 Episode 156
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews James Bussel, MD, emeritus professor of pediatrics, medicine, and obstetrics and gynecology at New York's Weill Cornell Medicine. The topic of their discussion is nipocalimab as a potential treatment for fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Published on 10 months, 3 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate